These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 34499522)

  • 1. Non-P450 Drug-Metabolizing Enzymes: Contribution to Drug Disposition, Toxicity, and Development.
    Fukami T; Yokoi T; Nakajima M
    Annu Rev Pharmacol Toxicol; 2022 Jan; 62():405-425. PubMed ID: 34499522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidation of endobiotics mediated by xenobiotic-metabolizing forms of human cytochrome.
    Niwa T; Murayama N; Yamazaki H
    Curr Drug Metab; 2009 Sep; 10(7):700-12. PubMed ID: 19594405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular non-P450 oxidative, reductive, hydrolytic, and conjugative drug metabolizing enzymes.
    Argikar UA; Dumouchel JL; Dunne CE; Bushee AJ
    Drug Metab Rev; 2017 Aug; 49(3):372-394. PubMed ID: 28438049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel cytochrome P450 mono-oxygenase from Streptomyces platensis resembles activities of human drug metabolizing P450s.
    Worsch A; Eggimann FK; Girhard M; von Bühler CJ; Tieves F; Czaja R; Vogel A; Grumaz C; Sohn K; Lütz S; Kittelmann M; Urlacher VB
    Biotechnol Bioeng; 2018 Sep; 115(9):2156-2166. PubMed ID: 29943426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphic metabolism by functional alterations of human cytochrome P450 enzymes.
    Lee IS; Kim D
    Arch Pharm Res; 2011 Nov; 34(11):1799-816. PubMed ID: 22139682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of cytochrome P450 enzymes in pharmacology and toxicology: Past, present, and future.
    Guengerich FP
    Adv Pharmacol; 2022; 95():1-47. PubMed ID: 35953152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of human cytochrome P450 3A4 and 3A5 in the metabolism of taxotere and its derivatives: enzyme specificity, interindividual distribution and metabolic contribution in human liver.
    Shou M; Martinet M; Korzekwa KR; Krausz KW; Gonzalez FJ; Gelboin HV
    Pharmacogenetics; 1998 Oct; 8(5):391-401. PubMed ID: 9825831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanism of phase I and phase II drug-metabolizing enzymes: implications for detoxification.
    Iyanagi T
    Int Rev Cytol; 2007; 260():35-112. PubMed ID: 17482904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytochrome P450 and Non-Cytochrome P450 Oxidative Metabolism: Contributions to the Pharmacokinetics, Safety, and Efficacy of Xenobiotics.
    Foti RS; Dalvie DK
    Drug Metab Dispos; 2016 Aug; 44(8):1229-45. PubMed ID: 27298339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Streptomyces cytochromes P450: applications in drug metabolism.
    Lamb DC; Waterman MR; Zhao B
    Expert Opin Drug Metab Toxicol; 2013 Oct; 9(10):1279-94. PubMed ID: 23738914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of Non-Cytochrome P450-Mediated Metabolism in Food and Drug Administration-Approved Oral and Intravenous Drugs: 2006-2015.
    Cerny MA
    Drug Metab Dispos; 2016 Aug; 44(8):1246-52. PubMed ID: 27084892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in Toxicological and Pharmacological Responses Mediated by Polymorphic Cytochromes P450 and Related Drug-Metabolizing Enzymes.
    Yamazaki H
    Chem Res Toxicol; 2017 Jan; 30(1):53-60. PubMed ID: 27750412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methodologies for investigating drug metabolism at the early drug discovery stage: prediction of hepatic drug clearance and P450 contribution.
    Emoto C; Murayama N; Rostami-Hodjegan A; Yamazaki H
    Curr Drug Metab; 2010 Oct; 11(8):678-85. PubMed ID: 20973757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochrome P450 in Pharmacogenetics: An Update.
    Tornio A; Backman JT
    Adv Pharmacol; 2018; 83():3-32. PubMed ID: 29801580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytochrome P450-activated prodrugs: targeted drug delivery.
    Huttunen KM; Mähönen N; Raunio H; Rautio J
    Curr Med Chem; 2008; 15(23):2346-65. PubMed ID: 18855665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An overview of the cytochrome P450 enzymes that catalyze the same-site multistep oxidation reactions in biotechnologically relevant selected actinomycete strains.
    Iizaka Y; Sherman DH; Anzai Y
    Appl Microbiol Biotechnol; 2021 Apr; 105(7):2647-2661. PubMed ID: 33710358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in molecular modeling of human cytochrome P450 polymorphism.
    Martiny VY; Miteva MA
    J Mol Biol; 2013 Nov; 425(21):3978-92. PubMed ID: 23856621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of Individual Human Cytochrome P450 Enzymes in Drug Metabolism.
    Guengerich FP
    Pharmacol Rev; 2024 Oct; 76(6):1104-1132. PubMed ID: 39054072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects.
    Lynch T; Price A
    Am Fam Physician; 2007 Aug; 76(3):391-6. PubMed ID: 17708140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxygen Surrogate Systems for Supporting Human Drug-Metabolizing Cytochrome P450 Enzymes.
    Strohmaier SJ; De Voss JJ; Jurva U; Andersson S; Gillam EMJ
    Drug Metab Dispos; 2020 Jun; 48(6):432-437. PubMed ID: 32238418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.